Am J Gastroenterol

1. SHAH T, Ansari Z, Ahmad A, Coyle W, et al
   Spray Cryotherapy Esophageal Consortium (SPEC) Consensus Recommendations for Liquid Nitrogen Spray Cryotherapy in Barrett's Esophagus and Esophageal Cancer using a Modified Delphi Process.
   Am J Gastroenterol. 2025 Aug 26. doi: 10.14309/ajg.0000000000003752.
   

   >> Share

   
   

   
   Am J Surg

2. FINNERTY BM, Marshall T, Annesi CA, Zarnegar R, et al
   Thyroid-stimulating immunoglobulin is not associated with aggressive clinicopathologic features in concomitant Graves' disease and papillary thyroid cancer.
   Am J Surg. 2025;247:116487.
   

   >> Share

   
   
3. AKINYEMI O, Weldeslase T, Fasokun M, Eze O, et al
   Medicaid expansion and thyroid cancer stage at presentation: A comparative study of two US states.
   Am J Surg. 2025;247:116447.
   

   >> Share

   
   

   
   Ann Surg

4. OKUI J, Matsuda S, Nagashima K, Sato Y, et al
   Recurrence-free Survival as a Surrogate Endpoint for Overall Survival in Resectable Esophageal Cancer: Integrated Analysis of Individual Patient Data From Phase III Trials.
   Ann Surg. 2025 Aug 25. doi: 10.1097/SLA.0000000000006919.
   

   >> Share

   
   

   
   BMC Cancer

5. LIU L, Liu J, Rong Y, Zhang S, et al
   Comparative study of neoadjuvant chemoradiotherapy, chemotherapy, and chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma.
   BMC Cancer. 2025;25:1320.
   

   >> Share

   
   
6. MAO Y, Gao Z, Sun Y, Shao C, et al
   Four-year follow-up from the phase 2 study TD-NICE: neoadjuvant treatment of tislelizumab combined with chemotherapy in resectable esophageal squamous cell carcinoma.
   BMC Cancer. 2025;25:1328.
   

   >> Share

   
   
7. JEONG HJ, Lee JS, Lee JS, Yun HJ, et al
   Anti-thyroglobulin antibody levels post-thyroidectomy and papillary thyroid carcinoma recurrence.
   BMC Cancer. 2025;25:1371.
   

   >> Share

   
   
8. PANG F, Wu L, Qiu J, Guo Y, et al
   Machine learning models for diagnosing lymph node recurrence in postoperative PTC patients: a radiomic analysis.
   BMC Cancer. 2025;25:1308.
   

   >> Share

   
   
9. YANG Q, Zhou X, Li J, Wang J, et al
   Comparative analysis and optimization of tumor regression grade assessment systems in neoadjuvant therapy for esophageal squamous cell carcinoma.
   BMC Cancer. 2025;25:1341.
   

   >> Share

   
   
10. LU Z, Zhu B, Ling H, Chen X, et al
    Deep learning radiomics based on MRI for differentiating tongue cancer T - staging.
    BMC Cancer. 2025;25:1358.
    

    >> Share

    
    
11. TAN C, Li Y, Jiang C, He L, et al
    DWI-guided DP-IMRT and conventional MRI-based IMRT in head and neck squamous cell carcinoma: a comparative study.
    BMC Cancer. 2025;25:1364.
    

    >> Share

    
    
12. WU H, Shu W, Ding Y, Li Q, et al
    The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy.
    BMC Cancer. 2025;25:1369.
    

    >> Share

    
    

    
    Br J Cancer

13. LI Y, Yuan X, Yin XF, Zheng D, et al
    Proteomics analysis and immune profiling reveal regulators of PD-L1 in oesophageal squamous cell carcinoma.
    Br J Cancer. 2025;133:448-463.
    

    >> Share

    
    

    
    Br J Ophthalmol

14. FAN W, Jager MJ, Dai W, Heindl LM, et al
    Deep learning-based system for automatic identification of benign and malignant eyelid tumours.
    Br J Ophthalmol. 2025 May 10:bjo-2025-327127. doi: 10.1136/bjo-2025-327127.
    

    >> Share

    
    

    
    Cancer

15. BAI M, Lu Y, Shen L, Yin X, et al
    Anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) in patients with advanced esophageal squamous cell carcinoma: A multicenter, open-label, phase 1b clinical trial.
    Cancer. 2025;131:e70046.
    

    >> Share

    
    

    
    Cancer Res

16. ROY S, Miyauchi S, Jones RN, Kim SS, et al
    HPV E5 Mediates Resistance to Chemotherapy and Radiation by Promoting a Stem Cell-Like Phenotype in Head and Neck Squamous Cell Carcinoma.
    Cancer Res. 2025 Aug 21. doi: 10.1158/0008-5472.CAN-24-3989.
    

    >> Share

    
    
17. CONTICELLI D, Volante M, Pietrantonio F, Orru C, et al
    AREG and EREG Are Predictive Biomarkers of Response to EGFR Inhibition in Gastroesophageal Cancer.
    Cancer Res. 2025;85:3111-3122.
    

    >> Share

    
    

    
    Clin Cancer Res

18. HARING CT, Windon MJ, Heft-Neal ME, Brenner JC, et al
    Toward a Next-Generation Liquid Biopsy for HPV+ HNSCC: Opportunities, Challenges, and the Road Ahead.
    Clin Cancer Res. 2025;31:3359-3361.
    

    >> Share

    
    

    
    Dis Esophagus

19. CHEVALLAY M, Barman S, Moss C, Van Hemelrijck M, et al
    Impact of endoscopic pyloric dilatation on symptom relief in delayed gastric emptying after esophageal resection-use of a novel symptom response questionnaire.
    Dis Esophagus. 2025;38:doaf067.
    

    >> Share

    
    

    
    Head Neck

20. COGNETTI DM, Curry JM, Johnson J, Kwon M, et al
    Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.
    Head Neck. 2025 Aug 25. doi: 10.1002/hed.70014.
    

    >> Share

    
    

    
    Hum Pathol

21. TANDON A, Sinehaa S, Saifi S, Adhya AK, et al
    BSND: An emerging immunohistochemical marker that reliably distinguishes benign from malignant oncocytic salivary gland tumors.
    Hum Pathol. 2025;161:105870.
    

    >> Share

    
    
22. YANG D, Li T, Li L, Chen S, et al
    Multi-modal convolutional neural network-based thyroid cytology classification and diagnosis.
    Hum Pathol. 2025;161:105868.
    

    >> Share

    
    

    
    Int J Pediatr Otorhinolaryngol

23. MATAN MB, Tahlil AA, Mohamed NA, Tahlil AM, et al
    Laryngeal squamous cell carcinoma in a 4-year-Old child: A rare case report.
    Int J Pediatr Otorhinolaryngol. 2025;196:112482.
    

    >> Share

    
    
24. NGO QX, Le DT, Ngo DQ
    Risk factors associated with postoperative complications in pediatric thyroidectomy: A single-center Vietnamese experience.
    Int J Pediatr Otorhinolaryngol. 2025;196:112471.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

25. FAN C, Lee J, Stock S, Woody NM, et al
    Imaging Extranodal Extension (iENE) Predicts Higher Rates of Distant Recurrence for Human Papillomavirus-Positive Oropharyngeal Cancer.
    Int J Radiat Oncol Biol Phys. 2025;123:120-128.
    

    >> Share

    
    
26. ADRIAN G, Falklind NR, McDowell L, Gebre-Medhin M, et al
    Chemoradiotherapy vs Radiotherapy Alone in T1-2 Oropharyngeal Cancer with Low Volume Neck Disease: A Population-Based Cohort Study Utilizing the XXXXX Head and Neck Cancer Register.
    Int J Radiat Oncol Biol Phys. 2025 Aug 21:S0360-3016(25)06188.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

27. BILGIN C, Hibbert R, Oztepe F, Sfeir JG, et al
    Percutaneous Ablation of Parathyroid Adenomas: A Systematic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2025;110:e3150-e3162.
    

    >> Share

    
    

    
    J Laryngol Otol

28. LEE CW, Jia W, Norman R, Dando A, et al
    Oncological and functional outcomes for transoral robotic surgery versus radiotherapy in T1-2 N0-1 p16+ oropharyngeal carcinoma.
    J Laryngol Otol. 2025;139:730-737.
    

    >> Share

    
    

    
    Laryngoscope

29. MEEKS N, McAdoo A, Lee J, Hom M, et al
    Non-FDG-Avid Metastasis Detected by Molecular Imaging in Unknown Primary of the Head and Neck.
    Laryngoscope. 2025;135:3229-3231.
    

    >> Share

    
    
30. CHEN H, Evans L, Schaaff C, Labib M, et al
    Multidisciplinary Care for Anaplastic Thyroid Cancer-End-of-Life Care as a Standard of Care.
    Laryngoscope. 2025;135:3444-3451.
    

    >> Share

    
    
31. SALVADOR DM, Welsh CA, Dixon PR
    Large Fibroepithelial Polyp Initially Misdiagnosed as Hemangioma of the Middle Ear Extending Through External Auditory Meatus.
    Laryngoscope. 2025 May 6. doi: 10.1002/lary.32242.
    

    >> Share

    
    
32. CLARK A, Nam YS, MacKay C, Bullock M, et al
    Assessing the Accuracy, Safety, and Tolerance of Office-Based Endoscopic Biopsies for Laryngopharyngeal Lesions.
    Laryngoscope. 2025;135:3287-3295.
    

    >> Share

    
    
33. MEEKER MO, Ivancic R, de Silva B, Matrka LA, et al
    Dysplasia and Carcinoma in Recurrent Respiratory Papillomatosis Patients Older Than 45 Years.
    Laryngoscope. 2025;135:3313-3319.
    

    >> Share

    
    
34. MUELLER-DIESING F, Stoth M, Ludwig E, Rosenwald A, et al
    Moderate Laryngeal Dysplasia in the Context of Classification Systems and Clinical Decision Making.
    Laryngoscope. 2025;135:3296-3305.
    

    >> Share

    
    
35. FASSLER C, Topf MC, Miller A, Jin W, et al
    Development of a Cutting Guide for Osteocutaneous Radial Forearm Free Flap Harvest.
    Laryngoscope. 2025;135:3149-3157.
    

    >> Share

    
    
36. KAKI PC, Patel AM, Haleem A, Patel AR, et al
    Adjuvant Radiotherapy in pT1-2N0M0 Head and Neck Adenoid Cystic Carcinoma.
    Laryngoscope. 2025;135:3202-3212.
    

    >> Share

    
    
37. PARK AC, Fehrenbach MP, Davis RJ, Ayo-Ajibola O, et al
    Social Vulnerability Index as a Tool to Evaluate the Distribution of Head and Neck Oncology Surgeons.
    Laryngoscope. 2025;135:3178-3185.
    

    >> Share

    
    

    
    Oral Oncol

38. SCHROTER P, Christ LV, Dvornikovich K, Stritzke F, et al
    Randomized controlled trial of semi-individualized 3D-printed tissue retraction devices vs. standard shielding splints in head and neck cancer treated with intensity-modulated and particle radiotherapy (GUARD).
    Oral Oncol. 2025;169:107604.
    

    >> Share

    
    
39. ZHANG J, Liu DM
    Advancing self-management for head and neck cancer-related lymphedema: A promising step forward.
    Oral Oncol. 2025;169:107611.
    

    >> Share

    
    
40. LUO R, Wu J, Zhong W, Ai K, et al
    Letter to the editor - Commentary on "A preliminary exploration of surgical strategies for solitary papillary thyroid carcinoma on the isthmus".
    Oral Oncol. 2025;169:107610.
    

    >> Share

    
    
41. CHEN Y, Yan Y
    Comment on "A preliminary exploration of surgical strategies for solitary papillary thyroid carcinoma on the isthmus".
    Oral Oncol. 2025;169:107614.
    

    >> Share

    
    
42. DAI Y, Li WJ
    Comment on "Feasibility and preliminary efficacy of a lymphedema and fibrosis self-management program for head and neck cancer survivors: A pilot randomized controlled trial" by Deng J et al.
    Oral Oncol. 2025;169:107613.
    

    >> Share

    
    
43. KOLANDHASAMY P
    Letter to the Editor: Oncologic significance of the lateral margin in buccal cancer.
    Oral Oncol. 2025;168:107492.
    

    >> Share

    
    
44. ZHU L, Jing X, Ahn BC
    Turning tumor microenvironmental foes to friends: A new opportunity for thyroid cancer therapy and redifferentiation.
    Oral Oncol. 2025;168:107513.
    

    >> Share

    
    
45. MUTHU S
    Commentary on "Histopathological invasion patterns and prognosis in Oral Squamous Cell Carcinoma: A retrospective analysis of 560 cases".
    Oral Oncol. 2025;168:107542.
    

    >> Share

    
    
46. YANG J, Wu W, Liu J, Li J, et al
    Comprehensive integration of single-cell and bulk transcriptome to reveal plasma cell heterogeneity and a prognosis signature in head and neck squamous cell carcinoma.
    Oral Oncol. 2025;168:107595.
    

    >> Share

    
    
47. MROSK F, Vertic V, Richter M, Knodler L, et al
    Clinical and oncological outcome in locoregional advanced oral squamous cell carcinoma treated by primary chemoradiation.
    Oral Oncol. 2025;168:107601.
    

    >> Share

    
    
48. STRUCKMEIER AK, Konig D, Klutmann S, Smeets R, et al
    Sentinel lymph node biopsy in early-stage oral squamous cell carcinoma: clinical outcomes and optimal lymph node removal thresholds.
    Oral Oncol. 2025;168:107598.
    

    >> Share

    
    
49. BEIRIGER J, Bellamkonda N, White MJ, Liang S, et al
    Implementation of point-of-care genetic testing for head and neck paragangliomas: early experience and future directions.
    Oral Oncol. 2025;168:107600.
    

    >> Share

    
    
50. GILI R, Morbini P, Bossi P
    PD-L1 Expression in head and neck squamous cell carcinoma: qualitative or quantitative assessment? Is that enough or we need something more?
    Oral Oncol. 2025;168:107606.
    

    >> Share

    
    
51. PAN CY, Lin TS, Lee TP, Tsai SC, et al
    Transoral robotic surgery in oral tongue cancer patients with trismus: a retrospective evaluation of feasibility and surgical outcomes.
    Oral Oncol. 2025;168:107597.
    

    >> Share

    
    
52. XU S, Lv Y, He H, Han C, et al
    Immune stratification in HPV-negative HNSCC: prognostic significance and prediction of immunotherapy response.
    Oral Oncol. 2025;168:107605.
    

    >> Share

    
    
53. NOEL CW, Birkenbeuel J, Ozer E, Agrawal A, et al
    Patterns of referral and outcomes in oropharyngeal cancer management.
    Oral Oncol. 2025;168:107602.
    

    >> Share

    
    
54. TREECHAIRUSAME T, Singh A, Dee EC, Oh JH, et al
    Osteoradionecrosis as a complication following post-operative intensity-modulated radiation therapy or proton therapy for oral cavity cancer.
    Oral Oncol. 2025;168:107581.
    

    >> Share

    
    
55. GURIZZAN C, Licata AG, Lorini L, Piazza C, et al
    The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disorders.
    Oral Oncol. 2025;168:107583.
    

    >> Share

    
    
56. MARQUARDT MD, Freeman T, Pancake A, Lee J, et al
    In-house 3D modeling associated with margin-negative resection in mandibular oral cavity malignancies.
    Oral Oncol. 2025;168:107588.
    

    >> Share

    
    
57. ABRUZZO AR, Harris MTH, Sroussi HY, Suzuki J, et al
    Oral cavity cancer after sublingual buprenorphine use.
    Oral Oncol. 2025;168:107573.
    

    >> Share

    
    
58. SOOD R, Singh CA, Panda S, Kakkar A, et al
    Predictors of recurrence, and the impact of adjuvant radiation therapy on survival in early stage (pT1-2, N0) oral cavity squamous cell carcinoma: A matched pair analysis.
    Oral Oncol. 2025;168:107566.
    

    >> Share

    
    
59. HERMAN M, Michalek J, Pink R, Kopecka K, et al
    Prognostic impact of immune phenotype in oral squamous cell carcinoma.
    Oral Oncol. 2025;168:107568.
    

    >> Share

    
    
60. KRISHNA R, Kumar P, Urs AB, Mohanty S, et al
    Epithelioid angiosarcoma of the oral cavity: a histopathological and immunohistochemical diagnostic conundrum.
    Oral Oncol. 2025;168:107564.
    

    >> Share

    
    
61. NARENKUMAR J, Parthipan P
    Letter to the Editor: Impact of the COVID-19 pandemic on diagnosis and disease stage in HPV-positive oropharyngeal cancer: insights and future directions.
    Oral Oncol. 2025;168:107541.
    

    >> Share

    
    

    
    PLoS One

62. GAO W, Yuan H, Qing S
    Bioinformatics analysis and experimental validation of the potential relationship between bacterial lipopolysaccharide and oral squamous cell carcinoma.
    PLoS One. 2025;20:e0329231.
    

    >> Share

    
    
63. CHEN B, Zhan Z, Yu S, Huang J, et al
    Burden of laryngeal cancer attributable to occupational asbestos exposure in China: A comprehensive analysis from 1990 to 2021.
    PLoS One. 2025;20:e0330878.
    

    >> Share

    
    

    
    Radiology

64. JABEHDAR MARALANI P, Kang HT
    Middle Neck Involvement: New Layer of Risk Stratification in Nasopharyngeal Carcinoma.
    Radiology. 2025;316:e252512.
    

    >> Share

    
    
65. QIN GJ, Jiang W, Zhang WQ, Li WF, et al
    MRI-based Middle Neck Involvement in Stage N1-N2 Nasopharyngeal Carcinoma: A Marker for Risk Stratification.
    Radiology. 2025;316:e243399.
    

    >> Share

    
    

    
    Radiother Oncol

66. HANSEN CR, Samsoe E, Smulders B, Sand HMB, et al
    Radiotherapy quality assurance of patients with squamous cell carcinoma of the head and neck included in the DAHANCA 19 randomised phase III trial.
    Radiother Oncol. 2025;211:111096.
    

    >> Share

    
    
67. WONG HCY, Karam I, Corbin K, Tse SSW, et al
    Bao Yuan Gao vs. Calendula cream for radiotherapy-induced skin toxicity in head and neck cancer: A randomized controlled trial - A biased negative trial essentially.
    Radiother Oncol. 2025;211:111109.
    

    >> Share

    
    

    
    Surgery

68. MYLONAKIS A, Dimitrakoudi M, Vasilatou D, Tsapralis D, et al
    Primary esophageal lymphoma: An individual participant data meta-analysis.
    Surgery. 2025;185:109534.
    

    >> Share

    
    

    
    Thyroid

69. RINGEL MD, Sosa JA, Baloch Z, Bischoff L, et al
    2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer.
    Thyroid. 2025;35:841-985.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share